Lataa...
Ischaemic Heart Disease: A Secondary Prevention Trial Using Clofibrate
A trial is reported of the effects of giving clofibrate to prevent progression of pre-existing ischaemic heart disease. There were two groups randomly distributed between clofibrate (350 patients) and placebo (367 patients) regimens. The trial lasted about six years and was conducted in 19 hospitals...
Tallennettuna:
| Aineistotyyppi: | Artigo |
|---|---|
| Kieli: | Inglês |
| Julkaistu: |
1971
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1799730/ https://ncbi.nlm.nih.gov/pubmed/4943606 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|